about
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technol...
Read More
97.15
-1.38
(-1.40%)
2.0M
XNAS Volume
XNAS 15 Jul, 2025 5:30 PM (EDT)
Medium Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them.
View Similar
Embed DVM
Illumina Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..